<DOC>
	<DOCNO>NCT02879903</DOCNO>
	<brief_summary>The aim present study identify 5 type fimbrial subunit genotype strain smoker nonsmoker periodontitis , periodontal therapy . Third two periodontitis patient select study , 16 nonsmoker 16 smoker . Clinical microbiological parameter evaluate baseline 3 month periodontal treatment : Plaque Index , Bleeding On Probe , Probing Depth , Gingival Recession Clinical Attachment Level . The prevalence P. gingivalis fimbrial subunit gene strain determine Polymerase Chain Reaction .</brief_summary>
	<brief_title>Prevalence Porphyromonas Gingivalis Fimbrial Subunit Genotype Smokers Nonsmokers After Periodontal Therapy</brief_title>
	<detailed_description>Porphyromonas gingivalis one prevalent periodontopathogens present red complex consider infectious agent cause several type periodontal disease . P. gingivalis ability invade gingival epithelial cell survive extend period time . Fimbriae characterize key factor adhesion , invasion , colonization . Fimbriae also responsible invasion membrane vesicle host cell . Long fimbria ( FimA ) , also know major fimbria , long , peritrichous , filamentous component . They role initial attachment organization biofilms , act adhesins mediate invasion colonization host cell contribute P. gingivalis virulence . Fimbrillin ( FimA ; structural subunit protein fimbria ) classify 5 variant ( type I V ) base nucleotide sequence . P. gingivalis strain possess type II fimA correlate P. gingivalis-positive patient , occurrence significantly increase severe form periodontitis . Previous study evaluate difference among prevalence fimA genotype periodontal health status adult . P. gingivalis detect 36.8 % healthy subject 87.1 % periodontitis patient . Among P. gingivalis-positive healthy adult , prevalent fimA type type I ( 76.1 % ) , follow type V ( 29.7 % ) . In contrast , majority periodontitis patient carry type II fimA organism ( 66.1 % ) , follow type IV ( 28.9 % ) . These finding indicate disease-associated non-disease-associated strain P. gingivalis , infectious trait influence periodontal health status could differentiate base clonal variation fimA gene . Tobacco consumption risk factor periodontal disease . Several study report smoker habit associate great clinical attachment loss , recession tooth loss reduce bone height density . However , controversial report discuss difference smoker non-smokers periodontopathogens . P. gingivalis report 52.2 % prevalence non-smokers 66.7 % smoker ( pocket depth 3-5 mm ) , associate high level sit periodontitis . The mechanism tobacco affect periodontal tissue relate nicotine associate various cellular change may contribute initiation subsequent progression periodontal disease . It promote local effect like reduction gingival blood flow , due long-term effect inflammatory lesion , high incidence gingival recession others clinical parameter smoker correlate cytotoxic vasoactive substance present tobacco , include nicotine , carbon monoxide reactive oxidant substance systemic effect smoke responsible 90 % case lung cancer , type deadliest cancer men woman smoker , well associate various lung disease . Furthermore , promote oxidative stress alteration immunoinflammatory response , reduce functional activity leucocyte , macrophage , lymphocytes immune cell , impair wound heal microbial recognition . Nonsurgical therapy use scale root plan usual periodontal therapy , well-recognized improvement clinical microbiological parameter . Fewer study evaluate longitudinal clinical microbiological status smoker undergo periodontal maintenance therapy controversial result find absence difference disease progression comparison nonsmoker . P. gingivalis reduce periodontal treatment . Previous report relate reduction 93 % P.gingivalis non-smokers 88 % smoker periodontal treatment .</detailed_description>
	<mesh_term>Periodontitis</mesh_term>
	<mesh_term>Chronic Periodontitis</mesh_term>
	<criteria>Clinical diagnosis chronic periodontitis Consumption 10 cigarettes/day . Diabetes mellitus Osteoporosis Pregnant lactate female Immune suppressive medication Phenytoin Cyclosporine Calcium channel blocker Immunotherapy diagnose HIV+</criteria>
	<gender>All</gender>
	<minimum_age>27 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>Porphyromonas gingivalis</keyword>
	<keyword>Periodontal treatment</keyword>
	<keyword>Smokers</keyword>
</DOC>